Aromatic Rings as Molecular Determinants for the Molecular Recognition of Protein Kinase Inhibitors. [PDF]
Zhu Y, Alqahtani S, Hu X.
europepmc +1 more source
Molecular Mechanisms of Alzheimer's Disease Induced by Amyloid-β and Tau Phosphorylation Along with RhoA Activity: Perspective of RhoA/Rho-Associated Protein Kinase Inhibitors for Neuronal Therapy. [PDF]
Ahn EH, Park JB.
europepmc +1 more source
Current progress, challenges and future prospects of indazoles as protein kinase inhibitors for the treatment of cancer. [PDF]
Tandon N+4 more
europepmc +1 more source
Recent Advances in Structural Optimization of Quinazoline-Based Protein Kinase Inhibitors for Cancer Therapy (2021-Present). [PDF]
Abdel-Mohsen HT+4 more
europepmc +1 more source
Synthesis of 4,5-Dihydro-1H-[1,2]dithiolo[3,4-c]quinoline-1-thione Derivatives and Their Application as Protein Kinase Inhibitors. [PDF]
Medvedeva SM, Shikhaliev KS.
europepmc +1 more source
Impact of Xerosis in Patients with Cancer Receiving Epidermal Growth Factor Receptor or Mitogen-Activated Protein Kinase Inhibitors: ATIXI, A Non-Interventional Prospective Pilot Study. [PDF]
Quaglino P+11 more
europepmc +1 more source
Cyclic Peptides as Protein Kinase Inhibitors: Structure-Activity Relationship and Molecular Modeling. [PDF]
Sanner MF+6 more
europepmc +1 more source
RHO-Associated Coiled-Coil-Containing Protein Kinase Inhibitors Significantly Modulate the Epithelial-Mesenchymal Transition Induced by TGF-β2 in the 2-D and 3-D Cultures of Human Corneal Stroma Fibroblasts. [PDF]
Umetsu A+7 more
europepmc +1 more source
Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades. [PDF]
Imran M+17 more
europepmc +1 more source
Molecular and cellular effects of the combined treatment with Camptothecin and Roscovitine in human lung and colon adenocarcinoma cells [PDF]
De Mattia, Roberta
core +1 more source